SPY441.40-4.34 -0.97%
DIA345.64-1.80 -0.52%
IXIC15,043.97-137.96 -0.91%

BRIEF-Autolus Therapeutics Announces Publication Of Obe-Cel (Auto1) Phase 1 Allcar19 Data In Adults With Relapsed/ Refractory B-All In Journal Of Clinical Oncology

reuters.com · 09/01/2021 07:25
BRIEF-Autolus Therapeutics Announces Publication Of Obe-Cel (Auto1) Phase 1 Allcar19 Data In Adults With Relapsed/ Refractory B-All In Journal Of Clinical Oncology

- Autolus Therapeutics PLC AUTL:

  • AUTOLUS THERAPEUTICS ANNOUNCES PUBLICATION OF OBE-CEL (AUTO1) PHASE 1 ALLCAR19 DATA IN ADULTS WITH RELAPSED/ REFRACTORY B-ALL IN JOURNAL OF CLINICAL ONCOLOGY

Source text for Eikon: ID:nGNX5tCj9W

Further company coverage: AUTL


((Reuters.Briefs@thomsonreuters.com;))